Hamsphire, Winchester, United Kingdom
Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection
Phase
4Span
293 weeksSponsor
Labo'LifeAartselaar
Recruiting
1-1 of 1